Unknown

Dataset Information

0

MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.


ABSTRACT: MicroRNA (miR) are important regulators of gene expression, and aberrant miR expression has been linked to oncogenesis; however, little is understood about their contribution to lung tumorigenesis. Here, we determined that miR-31 is overexpressed in human lung adenocarcinoma and this overexpression independently correlates with decreased patient survival. We developed a transgenic mouse model that allows for lung-specific expression of miR-31 to test the oncogenic potential of miR-31 in the lung. Using this model, we observed that miR-31 induction results in lung hyperplasia, followed by adenoma formation and later adenocarcinoma development. Moreover, induced expression of miR-31 in mice cooperated with mutant KRAS to accelerate lung tumorigenesis. We determined that miR-31 regulates lung epithelial cell growth and identified 6 negative regulators of RAS/MAPK signaling as direct targets of miR-31. Our study distinguishes miR-31 as a driver of lung tumorigenesis that promotes mutant KRAS-mediated oncogenesis and reveals that miR-31 directly targets and reduces expression of negative regulators of RAS/MAPK signaling.

SUBMITTER: Edmonds MD 

PROVIDER: S-EPMC4701567 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.

Edmonds Mick D MD   Boyd Kelli L KL   Moyo Tamara T   Mitra Ramkrishna R   Duszynski Robert R   Arrate Maria Pia MP   Chen Xi X   Zhao Zhongming Z   Blackwell Timothy S TS   Andl Thomas T   Eischen Christine M CM  

The Journal of clinical investigation 20151214 1


MicroRNA (miR) are important regulators of gene expression, and aberrant miR expression has been linked to oncogenesis; however, little is understood about their contribution to lung tumorigenesis. Here, we determined that miR-31 is overexpressed in human lung adenocarcinoma and this overexpression independently correlates with decreased patient survival. We developed a transgenic mouse model that allows for lung-specific expression of miR-31 to test the oncogenic potential of miR-31 in the lung  ...[more]

Similar Datasets

| S-EPMC5520171 | biostudies-literature
| S-EPMC8179725 | biostudies-literature
| S-EPMC10196571 | biostudies-literature
| S-EPMC6881183 | biostudies-literature
| S-EPMC6135591 | biostudies-literature
| S-EPMC6205381 | biostudies-literature
| S-EPMC7575595 | biostudies-literature
| S-EPMC4681648 | biostudies-literature
| S-EPMC4305190 | biostudies-literature
| S-EPMC9519049 | biostudies-literature